Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Thioredoxin pseudogene 7** (TXNP7) is a genomic sequence closely related to the functional thioredoxin genes but contains disabling mutations or lacks regulatory elements that prevent its expression as a functional protein. Pseudogenes such as TXNP7 are generally non-functional, though some can have regulatory RNA roles; however, there is no current evidence of such a function for TXNP7. Functional thioredoxin proteins participate in redox regulation and oxidative stress response, but TXNP7 itself is not implicated in these processes and is not considered a drug target[4][2][8].\n\nTXNP7 is a designation for a pseudogene, not a bona fide gene product, enzyme, receptor, or other classical therapeutic target. This means it does not possess protein, enzymatic, or receptor function that would qualify it as a therapeutic target. Some pseudogenes have demonstrated regulatory functions through RNA-based mechanisms in specific cancers, but such functions have not been attributed to TXNP7 according to available knowledge and literature[2][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thioredoxin pseudogene 7 (TXNP7).